CompoAtlas

Glucosamine Chondroitine MSM

Food supplement declared in France, declaration No 2022-7-630

Glucosamine Chondroitine MSM (Orfito bioactive) is a food supplement declared in France. Status: retiré du marché le 5 February 2026. None of the rules we check flags an issue with its declared composition.

Brand
Orfito bioactive
Food business operator placing the product on the market
BioUltime
Status
Retiré du marché le 5 February 2026
Form
Comprimé
Daily dose
3 comprimés
Directions for use
3 comprimés par jour à avaler avec un verre d’eau au cours du ou des repas
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes

Declaration 212529, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Glucosamine sulfate 2 KClnot declared
Sulfate de chondroïtinenot declared
Méthylsulfonate de méthanenot declared

Additives

E460, E470b, E341

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes diabétiques, ou pré-diabétique, asthmatiques ou traitées par anti-vitamine K, aux personnes présentant une allergie alimentaire aux crustacés ou aux insectes, aux personnes dont l'alimentation est contrôlée pour le sodium, le potassium ou le calcium, aux femmes enceintes ou allaitantes et aux enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Méthylsulfonate de méthane
    Read the warning, when it applies and the studies cited

    MSM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Orfito bioactive

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line